AMGN
55
11
EMN
73
4
OKE
70
3
R
67
2
COP
51
-2
O
39
2
WM
74
-10
RIG
49
2
QRVO
83
6
ZTS
36
2
REGN
58
2
SYK
60
5
IR
82
2
DD
60
11
LOW
56
4
LRCX
61
5
SWKS
59
7
HCA
48
6
PCG
85
4
URI
76
8
AMGN
55
11
EMN
73
4
OKE
70
3
R
67
2
COP
51
-2
O
39
2
WM
74
-10
RIG
49
2
QRVO
83
6
ZTS
36
2
REGN
58
2
SYK
60
5
IR
82
2
DD
60
11
LOW
56
4
LRCX
61
5
SWKS
59
7
HCA
48
6
PCG
85
4
URI
76
8
Financhill
Back

Bio-Rad Laboratories 10K Form

Sell
29

BIO
Bio-Rad Laboratories

Last Price:
269.63
Seasonality Move:
2.11%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BIO News And Ratings

See the #1 stock for the next 7 days that we like better than BIO

BIO Financial Statistics

Sales & Book Value

Annual Sales: $2.67B
Cash Flow: $38.8M
Price / Cash Flow: 37.17
Annual Sales: $306.51
Price / Book: 0.9

Profitability

EPS (TTM): -21.49000
Net Income (TTM): $-637.32M
Gross Margin: $1.43B
Return on Equity: -7.08%
Return on Assets: -5.03%

Bio-Rad Laboratories Earnings Forecast

Key Bio-Rad Laboratories Financial Ratios

  • The Gross Profit Margin over the past 40 years for BIO is 53.42%.
  • The Selling, General & Administrative Expenses for BIO have been equal to 31.51% of Gross Profit Margin.
  • The Research & Development expenses have been 9.26% of Revenue.
  • The Interest Expense is -7.76% of Operating Income.
  • The Net Earning history of BIO is -23.86% of Total Revenues.
  • Per Share Earnings over the last 40 years have been positive in 27 years.

Bio-Rad Laboratories Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: BIO
CUSIP: 090572
Website: bio-rad.com

Debt

Debt-to-Equity Ratio: 0.14
Current Ratio: 5.83
Quick Ratio: 4.01

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 23.1

BIO Technical Analysis vs Fundamental Analysis

Sell
29
Bio-Rad Laboratories (BIO) is a Sell

Is Bio-Rad Laboratories a Buy or a Sell?